A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK–Irish A-STAR register

202411 citationsJournal Articlehybrid Open Access

Authors

Helen Alexander · King's College London

Rayka Malek · King's College London

David Prieto‐Merino · King's College London

Elizaveta Gribaleva · King's College London

Manisha Baden · King's College London

Paula Beattie · Royal Hospital for Children

Sara Brown ·

Abstract

This real-world comparison of CyA, dupilumab and MTX in AD suggests that dupilumab is consistently more effective than MTX and that CyA is most effective in very severe disease within 1 year of follow-up.

Topics & Keywords

Dermatology and Skin Diseases Asthma and respiratory diseases Adrenal Hormones and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Dermatology

Volume 191, Issue 6, pp. 988-999

DOI: 10.1093/bjd/ljae287

Field-Weighted Citation Impact: 5.83